Soybeans as bioreactors for biopharmaceuticals and industrial proteins

Genetics and Molecular Research

Volumn 10, Issue 3, 2011, Pages 1733-1752

  Vianna, G R ^a   Cunha, N B ^a   Murad, A M ^a   Rech, E L ^a  

^a EMBRAPA RECURSOS GENÉTICOS E BIOTECNOLOGIA   (Brazil)

Author keywords

Glycine max; Plant farming; Plant seed storage proteins; Protein storage vacuoles; Transgenic soybean

Indexed keywords

ALPHA INTERFERON; AMYLASE; APROLIZEAN; APRONEXIN; APROTININ; AVIDIN; BETA GLUCURONIDASE; BLOOD CLOTTING FACTOR 9; CYANOVIRIN N; CYTOCHROME C; GLUCOSYLCERAMIDASE; GLYCININ; HEMAGGLUTININ; HUMAN GROWTH HORMONE; LACTOFERRIN; LIPOXYGENASE; LYSOZYME; PROINSULIN; RECOMBINANT AVIDIN; RECOMBINANT PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRYPSIN; TRYPZEAN; UNCLASSIFIED DRUG;

BIOMASS; BIOREACTOR; CELL COMPARTMENTALIZATION; DRUG SYNTHESIS; GAUCHER DISEASE; GENE EXPRESSION SYSTEM; GENETIC ENGINEERING; LARGE SCALE PRODUCTION; MACROMOLECULE; METABOLIC ENGINEERING; NONHUMAN; PLANT SEED; PLANT TUBER; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVIEW; SEED YIELD; SOYBEAN; TRANSGENIC PLANT;

BIOLOGICAL AGENTS; BIOREACTORS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; SOYBEANS; VACUOLES;

GLYCINE MAX;

EID: 80955167004     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol10-3gmr1476     Document Type: Review

References (62)

1. Abud S, de Souza PI, Vianna GR, Leonardecz E, et al. (2007). Gene flow from transgenic to nontransgenic soybean plants in the Cerrado region of Brazil. Genet. Mol. Res. 6: 445-452.
2. Aragão FJL, Sarokin L, Vianna GR and Rech EL (2000). Selection of transgenic meristematic cells utilizing a herbicidal molecule results in the recovery of fertile transgenic soybean [Glycine max (L.) Merril] plants at a high frequency. Theor. Appl. Genet. 101: 1-6.
3. Barnes S, Shonsey EM, Eliuk SM, Stella D, et al. (2008). High-resolution mass spectrometry analysis of protein oxidations and resultant loss of function. Biochem. Soc. Trans. 36: 1037-1044.
4. Boothe J, Nykiforuk C, Shen Y, Zaplachinski S, et al. (2010). Seed-based expression systems for plant molecular farming. Plant Biotechnol. J. 8: 588-606.
5. Buhr T, Sato S, Ebrahim F, Xing A, et al. (2002). Ribozyme termination of RNA transcripts down-regulate seed fatty acid genes in transgenic soybean. Plant J. 30: 155-163.
6. Cavazzoni J, Volk T, Bugbee B and Dougher T (1999). Phasic temperature and photoperiod control for soybean using a modified CROPGRO model. Life Support. Biosph. Sci. 6: 273-278.
7. Christou P, McCabe DE and Swain WF (1988). Stable transformation of soybean callus by DNA-coated gold particles. Plant Physiol. 87: 671-674.
8. Cunha NB, Araujo AC, Leite A, Murad AM, et al. (2010). Correct targeting of proinsulin in protein storage vacuoles of transgenic soybean seeds. Genet. Mol. Res. 9: 1163-1170.
9. Cunha NB, Murad AM, Cipriano TM, Araujo AC, et al. (2011a). Expression of functional recombinant human growth hormone in transgenic soybean seeds. Transgenic Res. 20: 811-826.
10. Cunha NB, Murad AM, Ramos GL, Maranhao AQ, et al. (2011b). Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds. Transgenic Res. 20: 841-855.
11. Daniell H, Streatfield SJ and Wycoff K (2001). Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6: 219-226.
12. Demain AL and Vaishnav P (2009). Production of recombinant proteins by microbes and higher organisms. Biotechnol. Adv. 27: 297-306.
13. Edman P (1949). A method for the determination of amino acid sequence in peptides. Arch. Biochem. 22: 475.
14. Fischer R, Stoger E, Schillberg S, Christou P, et al. (2004). Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 7: 152-158.
15. Gleba Y, Klimyuk V and Marillonnet S (2005). Magnifection-a new platform for expressing recombinant vaccines in plants. Vaccine 23: 2042-2048.
16. Goeddel DV, Kleid DG, Bolivar F, Heyneker HL, et al. (1979). Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc. Natl. Acad. Sci. U. S. A. 76: 106-110.
17. Gomord V and Faye L (2004). Posttranslational modification of therapeutic proteins in plants. Curr. Opin. Plant Biol. 7: 171-181.
18. Gomord V, Sourrouille C, Fitchette AC, Bardor M, et al. (2004). Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. Plant Biotechnol. J. 2: 83-100.
19. Gomord V, Fitchette AC, Menu-Bouaouiche L, Saint-Jore-Dupas C, et al. (2010). Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol. J. 8: 564-587.
20. Graef G, LaVallee BJ, Tenopir P, Tat M, et al. (2009). A high-oleic-acid and low-palmitic-acid soybean: agronomic performance and evaluation as a feedstock for biodiesel. Plant Biotechnol. J. 7: 411-421.
21. Hinchee MAW, Connor-Ward DV, Newell CA, McDonnell RE, et al. (1988). Production of transgenic soybean plants using Agrobacterium-mediated DNA transfer. Nat. Biotechnol. 6: 915-922.
22. Holzhauser T, Wackermann O, Ballmer-Weber BK, Bindslev-Jensen C, et al. (2009). Soybean (Glycine max) allergy in Europe: Gly m 5 (beta-conglycinin) and Gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy. J. Allergy Clin. Immunol. 123: 452-458.
23. Houdebine LM (2009). Production of pharmaceutical proteins by transgenic animals. Comp. Immunol. Microbiol. Infect. Dis. 32: 107-121.
24. Hunter AP and Games DE (1994). Chromatographic and mass spectrometric methods for the identification of phosphorylation sites in phosphoproteins. Rapid. Commun. Mass Spectrom. 8: 559-570.
25. Jolliffe NA, Craddock CP and Frigerio L (2005). Pathways for protein transport to seed storage vacuoles. Biochem. Soc. Trans. 33: 1016-1018.
26. Kantolic AG and Slafer GA (2007). Development and seed number in indeterminate soybean as affected by timing and duration of exposure to long photoperiods after flowering. Ann. Bot. 99: 925-933.
27. Karg SR and Kallio PT (2009). The production of biopharmaceuticals in plant systems. Biotechnol. Adv. 27: 879-894.
28. Kawakatsu T and Takaiwa F (2010). Cereal seed storage protein synthesis: fundamental processes for recombinant protein production in cereal grains. Plant Biotechnol. J. 8: 939-953.
29. Krishnan HB, Kim WS, Jang S and Kerley MS (2009). All three subunits of soybean beta-conglycinin are potential food allergens. J. Agric. Food Chem. 57: 938-943.
30. L'Hocine L and Boye JI (2007). Allergenicity of soybean: new developments in identification of allergenic proteins, cross-reactivities and hypoallergenization technologies. Crit. Rev. Food Sci. Nutr. 47: 127-143.
31. Larrick JW and Thomas DW (2001). Producing proteins in transgenic plants and animals. Curr. Opin. Biotechnol. 12: 411-418.
32. Lee D and Natesan E (2006). Evaluating genetic containment strategies for transgenic plants. Trends Biotechnol. 24: 109-114.
33. Lienard D, Sourrouille C, Gomord V and Faye L (2007). Pharming and transgenic plants. Biotechnol. Annu. Rev. 13: 115-147.
34. Ma JK, Drake PM and Christou P (2003). The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet. 4: 794-805.
35. Mari A, Rasi C, Palazzo P and Scala E (2009). Allergen databases: current status and perspectives. Curr. Allergy Asthma Rep. 9: 376-383.
36. Nielson NC (1985). Structure of Soy Proteins. In: New Protein Foods (Altschul AM and Wilcke HL, eds.). Academic Press, New York.
37. Obembe OO, Popoola JO, Leelavathi S and Reddy SV (2011). Advances in plant molecular farming. Biotechnol. Adv. 29: 210-222.
38. Philip R, Darnowski DW, Maughan PJ and Vodkin LO (2001). Processing and localization of bovine beta-casein expressed in transgenic soybean seeds under control of a soybean lectin expression cassette. Plant Sci. 161: 323-335.
39. Rech EL, Vianna GR and Aragao FJ (2008). High-efficiency transformation by biolistics of soybean, common bean and cotton transgenic plants. Nat. Protoc. 3: 410-418.
40. Robić G, Farinas CS, Rech EL, Bueno SMA, et al. (2006). Downstream process engineering evaluation of transgenic soybean seeds as host for recombinant protein production. Biochem. Eng. J. 32: 7-12.
41. Robić G, Farinas CS, Rech EL and Miranda EA (2010). Transgenic soybean seed as protein expression system: aqueous extraction of recombinant beta-glucuronidase. Appl. Biochem. Biotechnol. 160: 1157-1167.
42. Roychaudhuri R, Sarath G, Zeece M and Markwell J (2004). Stability of the allergenic soybean Kunitz trypsin inhibitor. Biochim. Biophys. Acta 1699: 207-212.
43. Salamone D, Baranao L, Santos C, Bussmann L, et al. (2006). High level expression of bioactive recombinant human growth hormone in the milk of a cloned transgenic cow. J. Biotechnol. 124: 469-472.
44. Sethuraman N and Stadheim TA (2006). Challenges in therapeutic glycoprotein production. Curr. Opin. Biotechnol. 17: 341-346.
45. Sewekow E, Kessler LC, Seidel-Morgenstern A and Rothkotter HJ (2008). Isolation of soybean protein P34 from oil bodies using hydrophobic interaction chromatography. BMC Biotechnol. 8: 27.
46. Shevchenko A, Tomas H, Havlis J, Olsen JV, et al. (2006). In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1: 2856-2860.
47. Smith AK and Circle SJ (1938). Peptization of soybean proteins extraction of nitrogenous constituents from oil-bases with and without added slats. Ind. Eng. Chem. 30: 1414-1418.
48. Smith AK and Circle SJ (1972). Soybeans: Chemistry and Technology. 2nd edn. The AVI Publishing Company, New York.
49. Smith AK, Circle SJ and Brother GH (1938). Peptization of soybean proteins. The effect of neutral salts on the quantity of nitrogenous constituents extracted from oil-free meal. J. Am. Chem. Soc. 60: 1316-1320.
50. Spök A and Karner S (2008). Plant Molecular Farming. Opportunities and Challenges. Final Report. The Institute for Prospective Technological Studies, Serville.
51. Spök A, Twyman RM, Fischer R, Ma JK, et al. (2008). Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. Trends Biotechnol. 26: 506-517.
52. Staswick PE, Hermodson MA and Nielsen NC (1981). Identification of the acidic and basic subunit complexes of glycinin. J. Biol. Chem. 256: 8752-8755.
53. Stoger E, Ma JK, Fischer R and Christou P (2005). Sowing the seeds of success: pharmaceutical proteins from plants. Curr. Opin. Biotechnol. 16: 167-173.
54. Streatfield SJ (2007). Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol. J. 5: 2-15.
55. Tang GQ, Novitzky WP, Carol GH, Huber SC, et al. (2005). Oleate desaturase enzymes of soybean: evidence of regulation through differential stability and phosphorylation. Plant J. 44: 433-446.
56. Tremblay R, Wang D, Jevnikar AM and Ma S (2010). Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol. Adv. 28: 214-221.
57. Vianna GR, Cunha N and Rech E (2011a). Expression and accumulation of heterologous molecules in the protein storage vacuoles of soybean seeds. Protocol Exchange. Available at [http://www.nature.com/protocolexchange/protocols/2012]. Accessed May 10, 2011.
58. Vianna GR, Aragao FJ and Rech EL (2011b). A minimal DNA cassette as a vector for genetic transformation of soybean (Glycine max). Genet. Mol. Res. 10: 382-390.
59. Wilson N, Simpson R and Cooper-Liddell C (2009). Introductory glycosylation analysis using SDS-PAGE and peptide mass fingerprinting. Methods Mol. Biol. 534: 205-212.
60. Xiang P, Haas EJ, Zeece MG, Markwell J, et al. (2004). C-Terminal 23 kDa polypeptide of soybean Gly m Bd 28 K is a potential allergen. Planta 220: 56-63.
61. Xu J, Ge X and Dolan MC (2011). Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnol. Adv. 29: 278-299.
62. Zeitlin L, Olmsted SS, Moench TR, Co MS, et al. (1998). A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat. Biotechnol. 16: 1361-1364.